BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PT0511 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PT0511\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07300150-2690@assetmemo.bio
DTSTAMP:20261121T005823Z
DTSTART;VALUE=DATE:20281018
DTEND;VALUE=DATE:20281019
SUMMARY:PT0511: Phase 1 readout est. (NCT07300150)
DESCRIPTION:PT0511\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Study 
 of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tu
 mors\nEstimated primary completion: 18 October 2028. This is a ClinicalTri
 als.gov estimate\, not a confirmed readout date\, and it can move.\nDrug p
 age: https://assetmemo.bio/drug/pt0511#upcoming-events\nRegistry record: h
 ttps://clinicaltrials.gov/study/NCT07300150
URL:https://assetmemo.bio/drug/pt0511#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
